Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

NOCIL

WEBSITE BSE:500730 NSE: NOCIL LTD Inc. Year: 1961 Industry: Chemicals My Bucket: Add Stock

₹171.7 -0.4 | 0.2%

Last updated: 15:48

Consolidated Standalone

Last updated: 15:48

NOCIL Overview

NOCIL Ltd is an primarily India based company, which gives primary organic chemical substances. The Company is engaged in the business of manufacturing and trading of rubber chemical compounds. The Company manufacturers PILCURE Accelerators, Post Vulcanization Stabilizer, PILFLEX Antidegradants, PILNOX Antioxidants, and PILGARD Pre Vulcanization Inhibitor are used in both domestic, in addition to worldwide markets. The Company's products include PILCURE MBT, PILCURE MBTS, PILCURE ZMBT, PILCURE F, PILCURE CBS, PILCURE NS, PILCURE MOR, PILCURE TM...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

NOCIL Key Financials

Market Cap ₹2867 Cr.

Stock P/E 27.9

P/B 1.6

Current Price ₹171.7

Book Value ₹ 106.6

Face Value 10

52W High ₹211

Dividend Yield 1.17%

52W Low ₹ 125.4

Edit Ratio

NOCIL Share Price

₹ | |

Volume
Price

NOCIL Quarterly Price

Quarterly Monthly
Show Value Show %

NOCIL Peer Comparison

NOCIL Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 351 341 357 372 363 318 340 336 321 316
Other Income 4 6 25 9 8 9 6 7 10 6
Total Income 355 346 381 382 371 327 345 343 331 322
Total Expenditure 305 292 312 331 325 294 305 306 298 289
Operating Profit 50 55 69 50 46 33 40 37 33 33
Interest 0 1 0 0 1 0 0 0 0 0
Depreciation 13 13 13 13 13 14 13 14 14 14
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -5
Profit Before Tax 37 41 56 37 32 19 26 23 19 13
Provision for Tax 9 11 14 10 -10 6 5 6 6 4
Profit After Tax 27 30 42 27 42 13 21 17 12 9
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 27 30 42 27 42 13 21 17 12 9
Adjusted Earnings Per Share 1.6 1.8 2.5 1.6 2.5 0.8 1.2 1 0.7 0.6

NOCIL Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 719 715 742 968 1043 846 925 1571 1617 1445 1393 1313
Other Income 4 4 10 15 10 9 15 4 6 39 32 29
Total Income 723 719 752 982 1053 855 939 1575 1623 1484 1425 1341
Total Expenditure 606 576 583 702 750 668 794 1285 1364 1250 1255 1198
Operating Profit 117 143 169 280 303 187 146 290 259 234 170 143
Interest 17 9 2 1 1 1 1 1 1 2 2 0
Depreciation 14 15 20 24 24 34 37 48 56 53 54 55
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 -5
Profit Before Tax 86 119 147 255 278 152 107 241 202 180 114 81
Provision for Tax 29 41 50 85 93 22 19 65 53 47 11 21
Profit After Tax 57 78 97 170 185 131 88 176 149 133 103 59
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 57 78 97 170 185 131 88 176 149 133 103 59
Adjusted Earnings Per Share 3.6 4.9 5.9 10.3 11.2 7.9 5.3 10.6 9 8 6.2 3.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -4% -4% 10% 7%
Operating Profit CAGR -27% -16% -2% 4%
PAT CAGR -23% -16% -5% 6%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -9% -7% 0% 13%
ROE Average 6% 8% 9% 12%
ROCE Average 7% 10% 12% 17%

NOCIL Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 415 470 913 1047 1163 1185 1285 1445 1552 1699 1762
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 51 15 5 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 108 143 123 120 124 116 120 126 134 151 134
Total Current Liabilities 233 130 119 164 155 141 210 259 171 166 160
Total Liabilities 806 759 1161 1331 1442 1442 1615 1831 1857 2015 2057
Fixed Assets 311 307 542 527 657 797 917 909 887 869 855
Other Non-Current Assets 115 138 202 131 206 220 75 78 88 170 269
Total Current Assets 380 314 417 673 580 426 623 844 881 976 934
Total Assets 806 759 1161 1331 1442 1442 1615 1831 1857 2015 2057

NOCIL Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 14 5 4 106 24 37 9 45 12 24 92
Cash Flow from Operating Activities 30 170 142 102 164 179 94 -30 282 201 26
Cash Flow from Investing Activities -5 -12 -10 -142 -101 -106 -62 31 -217 -77 -37
Cash Flow from Financing Activities -33 -151 -31 -43 -50 -101 0 -34 -54 -55 -50
Net Cash Inflow / Outflow -8 7 102 -82 13 -28 32 -33 11 68 -62
Closing Cash & Cash Equivalent 6 13 106 24 37 9 45 12 24 92 30

NOCIL Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.55 4.87 5.94 10.33 11.17 7.89 5.32 10.57 8.95 7.98 6.16
CEPS(Rs) 4.45 5.78 7.14 11.79 12.64 9.93 7.57 13.47 12.29 11.15 9.37
DPS(Rs) 1 1.2 1.8 2.5 2.5 2.5 2 3 3 3 2
Book NAV/Share(Rs) 25.81 29.23 55.66 63.42 70.05 71.22 76.96 86.48 92.8 101.53 105.01
Core EBITDA Margin(%) 14.42 17.67 19.46 26.83 28.07 21.06 14.15 18.21 15.63 13.5 9.87
EBIT Margin(%) 13.08 16.27 18.21 25.87 26.69 18.16 11.69 15.38 12.58 12.57 8.32
Pre Tax Margin(%) 10.98 15.08 17.94 25.75 26.63 18 11.59 15.31 12.5 12.46 8.2
PAT Margin (%) 7.27 9.92 11.87 17.18 17.72 15.44 9.56 11.21 9.23 9.21 7.39
Cash Profit Margin (%) 9.12 11.78 14.28 19.61 20.06 19.43 13.61 14.28 12.67 12.86 11.23
ROA(%) 7.42 10 10.12 13.64 13.33 9.06 5.78 10.22 8.09 6.87 5.05
ROE(%) 14.41 17.69 14.07 17.4 16.79 11.18 7.19 12.95 9.99 8.21 5.97
ROCE(%) 18.74 24.04 20.84 25.85 25.14 13.09 8.75 17.71 13.56 11.17 6.7
Receivable days 73.18 73.65 70.83 75.62 83.22 93.89 101.01 88.08 89.84 86.68 85.23
Inventory Days 80.84 74.14 55.14 49.78 57.04 66.23 59.62 57.89 69.73 64.13 66.06
Payable days 71.63 64.94 62.2 53.3 54.23 71 71.68 57.73 52.57 41.66 35.94
PER(x) 10.6 9.47 15.81 18.52 13.17 8.34 32.83 23.59 23.05 31.24 28.4
Price/Book(x) 1.46 1.58 1.69 3.02 2.1 0.92 2.27 2.88 2.22 2.46 1.67
Dividend Yield(%) 2.66 2.6 1.92 1.31 1.7 3.8 1.15 1.2 1.45 1.2 1.14
EV/Net Sales(x) 1.04 1.06 1.92 3.22 2.3 1.27 3.05 2.63 2.09 2.81 2.07
EV/Core EBITDA(x) 6.38 5.3 8.46 11.15 7.91 5.74 19.39 14.27 13.05 17.32 17.04
Net Sales Growth(%) 20.61 -0.53 3.78 30.37 7.78 -18.85 9.26 69.93 2.88 -10.63 -3.6
EBIT Growth(%) 95.96 24.85 16.15 71.76 8.77 -44.8 -29.65 123.6 -15.9 -10.66 -36.17
PAT Growth(%) 139.37 37.06 24.1 74.97 8.78 -29.31 -32.34 99.2 -15.31 -10.83 -22.66
EPS Growth(%) 139.36 37.06 21.98 74.01 8.16 -29.39 -32.59 98.78 -15.34 -10.83 -22.83
Debt/Equity(x) 0.36 0.07 0.02 0 0 0 0 0 0 0 0
Current Ratio(x) 1.63 2.41 3.49 4.09 3.74 3.03 2.96 3.26 5.15 5.89 5.82
Quick Ratio(x) 0.83 1.39 2.53 3.15 2.64 2.06 2.17 1.97 3.49 4.55 4.07
Interest Cover(x) 6.22 13.73 67.12 209.77 441.86 116.41 111.44 221.75 169.41 112.1 64.77
Total Debt/Mcap(x) 0.25 0.04 0.01 0 0 0 0 0 0 0 0

NOCIL Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 33.84 33.84 33.84 33.79 33.78 33.76 33.76 33.76 33.76 33.76
FII 6.98 7.78 7.77 7.91 7.81 8.15 6.65 5.15 4.47 4.55
DII 2.83 3.51 4.44 6.13 5.91 5.26 5.18 6.55 6.48 7.89
Public 56.35 54.88 53.96 52.17 52.5 52.83 54.41 54.54 55.29 53.79
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

NOCIL News

NOCIL Pros & Cons

Pros

  • Debtor days have improved from 41.66 to 35.94days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 33.76%.
  • Company has a low return on equity of 8% over the last 3 years.
  • The company has delivered a poor profit growth of -4% over past five years.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!